IL-1, mainly IL-1β and Interleukin receptor antagonist (IL-Ra), plays crucial role in rheumatology. In line with it, GSDMD may adjust the expression of IL-1 to improve rheumatoid arthritis. This evidence concerns the gene IL7R and rheumatoid arthritis.